Jonathan B. Kahn, MD

  • Specialty: Ophthalmology
  • Language: English

About Me

Conditions and Treatments

eye surgery, myopia (nearsightedness), dry eye, stye, cataract, eye floater, refractive error, blepharitis, eye redness, presbyopia, ocular herpes, corneal disease, uveitis, hyperopia (farsightedness), conjunctivitis, astigmatism, glaucoma
Show More Conditions
Learn more about conditions we treat at NYU Langone:
Retinal Detachment, Refractive Error, Stye in Adults, Dry Eye Syndrome, Conjunctivitis, Glaucoma in Adults, Cataract in Adults

Credentials

Positions
  • Clinical Assistant Professor, Department of Ophthalmology
Board Certifications
  • American Board of Ophthalmology - Ophthalmology, 2013
Education and Training
  • Fellowship, NA, Corneal Disease, 2013
  • Residency, NYU Langone Medical Center, Ophthalmology, 2012
  • MD from Northwestern University, 2008
Departments

Is this your profile?

Edit profile

Is this your profile?

Edit profile

Research Academic Contact

Academic office

161 Madison Avenue, Suite 5-SE

New York, NY 10016

Phone

212-448-0101

Fax

212-448-0116

Clinical Trials and Research Studies

  • A Phase 1-2 Open-Label Dose-Finding Proof of Concept First-in-Human Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of CX-2009 in Adults with Metastatic or Locally Advanced Unresectable Solid Tumors

    Learn More

  • SGN22E-001: A single-arm open-label multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy

    Learn More

  • A Phase 1b Dose Escalation Study to Determine the Recommended Phase 2 Dose of TAK-659 in Combination With Bendamustine ( Rituximab) Gemcitabine Lenalidomide or Ibrutinib for the Treatment of Patients With Advanced Non-Hodgkin Lymphoma After At Least 1 Prior Line of Therapy

    Learn More
View All Research Studies (8)

Publications

Read All Publications (8)